Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies

Examining non-prescription syringe sales in Massachusetts and Rhode Island community pharmacies

(2021) Traci C. Green et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden

(2021) Neda J. Kazerouni et al.   DRUG AND ALCOHOL DEPENDENCE

Impact of the RESPOND Toolkit on community pharmacists’ opioid safety attitudes, self-efficacy, and knowledge

(2020) Adriane N. Irwin et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

“It's just basically a box full of disease” – Navigating sterile syringe scarcity in a rural New England state

(2020) Robin A. Pollini et al.   ADDICTION

Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches

(2020) Traci C. Green et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Assessing pharmacy-based naloxone access using an innovative purchase trial methodology

(2020) Robin A. Pollini et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic

(2020) Mark A. Strand et al.   Preventing Chronic Disease

Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York City

(2020) Bilal Abbas et al.   DRUG AND ALCOHOL DEPENDENCE

Pharmacists’ Response During a Pandemic: A Survey on Readiness to Test During COVID19

(2020) Matthew Lacroix et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA

(2020) Lucas G. Hill et al.   ADDICTION

Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose

(2019) Elizabeth Donovan et al.   JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE

Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians

(2019) Shawn Kurian et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Pharmacists’ attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature

(2019) Andrew Muzyk et al.   Substance Abuse

Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study

(2019) Daniel J. Ventricelli et al.   SUBSTANCE USE & MISUSE

Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study

(2019) Dina Burstein et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states

(2017) Traci C. Green et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015

(2017) Thomas J. Stopka et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Pharmacists’ Role in Opioid Safety: A Focus Group Investigation

(2017) Daniel M. Hartung et al.   PAIN MEDICINE

Nonprescription syringe sales: Resistant pharmacists’ attitudes and practices

(2016) Elizabeth Chiarello   DRUG AND ALCOHOL DEPENDENCE